Abstract
Successful Conversion Surgery after Tremelimumab plus Durvalumab Therapy for Unresectable Recurrent Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Case Report
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have